| Announce Date | 02/02/2026 |
| EPS Normalized Actual | $3.4 (Beat by $0.16) |
| EPS GAAP Actual | $3.4 (Beat by $0.16) |
| Revenue Actual | $3.61979B |
| Revenue Surprise | Beat by $3619.79M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.59955 |
| EPS GAAP Estimate | $2.59955 |
| Revenue Estimate | $3.276422128B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 18.59 | 8.07 | 18.29649 | 18.97107 | 1 |
| Dec 2028 | 16.91 | 8.87 | 16.50737 | 17.16955 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.51 | -0.58953 | 3.61979B | 8.98% | 333.65M |
| FQ3 2025 (Sep 2025) | 2.09 | -0.72699 | 3.42023B | 4.58% | 175.69M |
| FQ2 2025 (Jun 2025) | 2.6248 | -0.37035 | 3.37953B | 5.71% | 114.86M |
| FQ1 2025 (Mar 2025) | 2.05 | 2.05 | 3.22353B | 4.75% | 3223.53M |
| FQ4 2024 (Dec 2024) | 3.1 | 3.1 | 3.29468B | 4.52% | 3294.68M |
| FQ3 2024 (Sep 2024) | 2.47 | 2.47 | 3.26359B | 4.36% | 3263.59M |
| FQ2 2024 (Jun 2024) | 2.56 | 2.56 | 3.18672B | 5.85% | 3186.72M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 3.07055B | 6.44% | 3070.55M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.59955
Consensus Revenue Estimates
3.276422128B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.88762 | -- | 3.81468 | 3.95575 | 1 |
| FQ3 2027 (Sep 2027) | 4.3665 | -- | 4.34663 | 4.38637 | 1 |
| FQ2 2027 (Jun 2027) | 3.98942 | -- | 3.97127 | 4.00757 | 1 |
| FQ1 2027 (Mar 2027) | 2.96782 | -- | 2.91214 | 3.01983 | 1 |
| FQ4 2026 (Oct 2026) | 3.63658 | 30.98 | 3.5945 | 3.67779 | 0 |
| FQ3 2026 (Jul 2026) | 3.65258 | 42.78 | 3.61031 | 3.69398 | 0 |
| FQ2 2026 (Jun 2026) | 3.95725 | 33.67 | 3.90036 | 4.00666 | 0 |
| FQ1 2026 (Mar 2026) | 2.59955 | 21.14 | 2.56218 | 2.63201 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.57B | -- | 3.52B | 3.62B | 2 |
| FQ3 2027 (Sep 2027) | 3.67B | -- | 3.66B | 3.68B | 1 |
| FQ2 2027 (Jun 2027) | 3.57B | -- | 3.56B | 3.59B | 1 |
| FQ1 2027 (Mar 2027) | 3.42B | -- | 3.37B | 3.46B | 2 |
| FQ4 2026 (Oct 2026) | 3.38B | -6.95 | 3.35B | 3.41B | 1 |
| FQ3 2026 (Jul 2026) | 3.34B | -2.26 | 3.31B | 3.37B | 1 |
| FQ2 2026 (Jun 2026) | 3.39B | 0.28 | 3.35B | 3.42B | 2 |
| FQ1 2026 (Mar 2026) | 3.28B | 1.61 | 3.24B | 3.31B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.09953 | 2.51 | -0.58953 | -23.49% |
| FQ3 2025 (Sep 2025) | 2.81699 | 2.09 | -0.72699 | -34.78% |
| FQ2 2025 (Jun 2025) | 2.99515 | 2.6248 | -0.37035 | -14.11% |
| FQ1 2025 (Mar 2025) | 2.05 | 2.05 | 100% | |
| FQ4 2024 (Dec 2024) | 3.1 | 3.1 | 100% | |
| FQ3 2024 (Sep 2024) | 2.47 | 2.47 | 100% | |
| FQ2 2024 (Jun 2024) | 2.56 | 2.56 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $3.29B | $3.62B | $333.65M | 9.22% |
| FQ3 2025 (Sep 2025) | $3.24B | $3.42B | $175.69M | 5.14% |
| FQ2 2025 (Jun 2025) | $3.26B | $3.38B | $114.86M | 3.4% |
| FQ1 2025 (Mar 2025) | $0B | $3.22B | $3223.53M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.29B | $3294.68M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.26B | $3263.59M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.19B | $3186.72M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.07B | $3070.55M | 100% |